

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 5.58419115 |
| 2 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.57051841 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.52649845 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.50422547 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.32768636 |
| 6 | protein localization to synapse (GO:0035418) | 5.31575399 |
| 7 | glutamate secretion (GO:0014047) | 5.26841106 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.24569095 |
| 9 | neuronal action potential propagation (GO:0019227) | 5.14501092 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 5.10893987 |
| 11 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.04030156 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.02165453 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.94936370 |
| 14 | glutamate receptor signaling pathway (GO:0007215) | 4.92135682 |
| 15 | presynaptic membrane assembly (GO:0097105) | 4.86896149 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.85406751 |
| 17 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.68153730 |
| 18 | neuron-neuron synaptic transmission (GO:0007270) | 4.57048681 |
| 19 | synaptic transmission, glutamatergic (GO:0035249) | 4.55323641 |
| 20 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.48471827 |
| 21 | presynaptic membrane organization (GO:0097090) | 4.46088926 |
| 22 | piRNA metabolic process (GO:0034587) | 4.42853434 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 4.37075444 |
| 24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.35847290 |
| 25 | locomotory exploration behavior (GO:0035641) | 4.33378898 |
| 26 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.22566765 |
| 27 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.22286301 |
| 28 | postsynaptic membrane organization (GO:0001941) | 4.17901696 |
| 29 | synaptic vesicle maturation (GO:0016188) | 4.15453827 |
| 30 | positive regulation of synapse maturation (GO:0090129) | 4.11206024 |
| 31 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.11168272 |
| 32 | long-term synaptic potentiation (GO:0060291) | 4.10486864 |
| 33 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.09898327 |
| 34 | synapsis (GO:0007129) | 4.09510572 |
| 35 | response to histamine (GO:0034776) | 4.09331848 |
| 36 | regulation of postsynaptic membrane potential (GO:0060078) | 4.06222629 |
| 37 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.04874875 |
| 38 | neuron recognition (GO:0008038) | 4.00121524 |
| 39 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.87958725 |
| 40 | neurotransmitter secretion (GO:0007269) | 3.86896879 |
| 41 | male meiosis I (GO:0007141) | 3.81535708 |
| 42 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.80093346 |
| 43 | regulation of synaptic plasticity (GO:0048167) | 3.77668409 |
| 44 | exploration behavior (GO:0035640) | 3.74238816 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.67248688 |
| 46 | synaptic vesicle endocytosis (GO:0048488) | 3.64600233 |
| 47 | cerebellar granule cell differentiation (GO:0021707) | 3.59967305 |
| 48 | long-term memory (GO:0007616) | 3.59508679 |
| 49 | behavioral fear response (GO:0001662) | 3.58471358 |
| 50 | behavioral defense response (GO:0002209) | 3.58471358 |
| 51 | axonal fasciculation (GO:0007413) | 3.56581612 |
| 52 | regulation of glutamate secretion (GO:0014048) | 3.54551406 |
| 53 | startle response (GO:0001964) | 3.53725820 |
| 54 | positive regulation of membrane potential (GO:0045838) | 3.53679156 |
| 55 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.53063802 |
| 56 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.52841439 |
| 57 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.50555677 |
| 58 | fear response (GO:0042596) | 3.49382025 |
| 59 | regulation of neurotransmitter secretion (GO:0046928) | 3.47409074 |
| 60 | retinal cone cell development (GO:0046549) | 3.44502885 |
| 61 | positive regulation of meiosis (GO:0045836) | 3.43052219 |
| 62 | behavioral response to cocaine (GO:0048148) | 3.38511916 |
| 63 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.37771929 |
| 64 | DNA methylation involved in gamete generation (GO:0043046) | 3.37067585 |
| 65 | regulation of synapse maturation (GO:0090128) | 3.36636964 |
| 66 | regulation of vesicle fusion (GO:0031338) | 3.36234203 |
| 67 | membrane depolarization (GO:0051899) | 3.34813672 |
| 68 | positive regulation of neurotransmitter transport (GO:0051590) | 3.31540698 |
| 69 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.29692072 |
| 70 | male meiosis (GO:0007140) | 3.28667421 |
| 71 | transmission of nerve impulse (GO:0019226) | 3.27909903 |
| 72 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.27766637 |
| 73 | auditory behavior (GO:0031223) | 3.27064466 |
| 74 | detection of calcium ion (GO:0005513) | 3.26303605 |
| 75 | regulation of dendritic spine development (GO:0060998) | 3.26034359 |
| 76 | protein K11-linked deubiquitination (GO:0035871) | 3.24166685 |
| 77 | dendritic spine morphogenesis (GO:0060997) | 3.23439568 |
| 78 | cochlea development (GO:0090102) | 3.21379543 |
| 79 | neurotransmitter transport (GO:0006836) | 3.21059476 |
| 80 | regulation of meiosis I (GO:0060631) | 3.21006243 |
| 81 | long term synaptic depression (GO:0060292) | 3.20926272 |
| 82 | positive regulation of synapse assembly (GO:0051965) | 3.18180309 |
| 83 | positive regulation of meiotic cell cycle (GO:0051446) | 3.18012235 |
| 84 | learning (GO:0007612) | 3.16524623 |
| 85 | cellular potassium ion homeostasis (GO:0030007) | 3.14448669 |
| 86 | innervation (GO:0060384) | 3.12739558 |
| 87 | membrane depolarization during action potential (GO:0086010) | 3.12498027 |
| 88 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.12479571 |
| 89 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.10799542 |
| 90 | regulation of neurotransmitter transport (GO:0051588) | 3.10271728 |
| 91 | synaptic transmission (GO:0007268) | 3.09654908 |
| 92 | negative regulation of amino acid transport (GO:0051956) | 3.09255261 |
| 93 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.06557201 |
| 94 | serotonin metabolic process (GO:0042428) | 3.04900431 |
| 95 | regulation of synaptic transmission (GO:0050804) | 3.04210846 |
| 96 | proline transport (GO:0015824) | 3.04153886 |
| 97 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.02637349 |
| 98 | positive regulation of synaptic transmission (GO:0050806) | 3.02145100 |
| 99 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.00535808 |
| 100 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.00535808 |
| 101 | negative regulation of neurotransmitter transport (GO:0051589) | 3.00363091 |
| 102 | chromosome organization involved in meiosis (GO:0070192) | 3.00346935 |
| 103 | gamma-aminobutyric acid transport (GO:0015812) | 3.00231051 |
| 104 | activation of protein kinase A activity (GO:0034199) | 3.00039332 |
| 105 | regulation of synapse structural plasticity (GO:0051823) | 2.99431004 |
| 106 | dendritic spine organization (GO:0097061) | 2.99308567 |
| 107 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.98556217 |
| 108 | potassium ion import (GO:0010107) | 2.98065793 |
| 109 | synapse assembly (GO:0007416) | 2.97488373 |
| 110 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.97241261 |
| 111 | mechanosensory behavior (GO:0007638) | 2.94962477 |
| 112 | negative regulation of dendrite development (GO:2000171) | 2.94903252 |
| 113 | transferrin transport (GO:0033572) | 2.94636217 |
| 114 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.93447785 |
| 115 | meiosis I (GO:0007127) | 2.91473037 |
| 116 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.91086329 |
| 117 | L-amino acid import (GO:0043092) | 2.90513727 |
| 118 | regulation of neurotransmitter levels (GO:0001505) | 2.90019397 |
| 119 | primary amino compound metabolic process (GO:1901160) | 2.83645732 |
| 120 | growth hormone receptor signaling pathway (GO:0060396) | 2.81580730 |
| 121 | brain morphogenesis (GO:0048854) | 2.76481293 |
| 122 | C4-dicarboxylate transport (GO:0015740) | 2.76378353 |
| 123 | synaptonemal complex organization (GO:0070193) | 2.74003131 |
| 124 | chemosensory behavior (GO:0007635) | 2.73872628 |
| 125 | glycerophospholipid catabolic process (GO:0046475) | 2.72294219 |
| 126 | central nervous system myelination (GO:0022010) | 2.65367888 |
| 127 | axon ensheathment in central nervous system (GO:0032291) | 2.65367888 |
| 128 | neuronal action potential (GO:0019228) | 2.64007422 |
| 129 | regulation of protein glycosylation (GO:0060049) | 2.63957664 |
| 130 | establishment of protein localization to Golgi (GO:0072600) | 2.62978943 |
| 131 | potassium ion transmembrane transport (GO:0071805) | 2.60818566 |
| 132 | cellular potassium ion transport (GO:0071804) | 2.60818566 |
| 133 | neurotransmitter uptake (GO:0001504) | 2.58982021 |
| 134 | glycosphingolipid biosynthetic process (GO:0006688) | 2.53438512 |
| 135 | potassium ion transport (GO:0006813) | 2.52564067 |
| 136 | regulation of neurotransmitter uptake (GO:0051580) | 2.49670655 |
| 137 | cellular response to ethanol (GO:0071361) | 2.48966817 |
| 138 | protein targeting to Golgi (GO:0000042) | 2.48676510 |
| 139 | * positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.47956501 |
| 140 | response to pheromone (GO:0019236) | 2.47912443 |
| 141 | cellular response to growth hormone stimulus (GO:0071378) | 2.44188075 |
| 142 | nerve growth factor signaling pathway (GO:0038180) | 2.43652635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.23429967 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.57282407 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.12140465 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02892140 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.98472500 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.66819659 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.63007996 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.57549575 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.57258756 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.52460354 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.52460354 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44681048 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.44585148 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.38640823 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36594554 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.33955481 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.30963005 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30810290 |
| 19 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.27638596 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.27336381 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.23134726 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.16467813 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02203264 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.99820540 |
| 25 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.99649679 |
| 26 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.98335742 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.96824414 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.94723313 |
| 29 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.94542121 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.92221539 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.91841458 |
| 32 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.89645283 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.89334126 |
| 34 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.81681525 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.80796250 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.77359043 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76164964 |
| 38 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.75031576 |
| 39 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.70441924 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.67661043 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.67525028 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67339972 |
| 43 | VDR_22108803_ChIP-Seq_LS180_Human | 1.66903742 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.65601167 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64347216 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.63714766 |
| 47 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.62834039 |
| 48 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.60348308 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50854514 |
| 50 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48708051 |
| 51 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.47950585 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.46819976 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43413082 |
| 54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.43233090 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37650854 |
| 56 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.37183284 |
| 57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.37027051 |
| 58 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.36997261 |
| 59 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36757862 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.35942988 |
| 61 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.35933068 |
| 62 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35632743 |
| 63 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.35569360 |
| 64 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.35569360 |
| 65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35356651 |
| 66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.35203248 |
| 67 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34036375 |
| 68 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30780836 |
| 69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29308869 |
| 70 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.29252517 |
| 71 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.29172478 |
| 72 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.28239152 |
| 73 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26568589 |
| 74 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.26075254 |
| 75 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.25489491 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23610025 |
| 77 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.23523381 |
| 78 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.22871738 |
| 79 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21283359 |
| 80 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21136553 |
| 81 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19961444 |
| 82 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.19812831 |
| 83 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.19097285 |
| 84 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18053755 |
| 85 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.17603303 |
| 86 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.17209485 |
| 87 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.15729867 |
| 88 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14777853 |
| 89 | AR_19668381_ChIP-Seq_PC3_Human | 1.13854822 |
| 90 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13479089 |
| 91 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13424128 |
| 92 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.13178565 |
| 93 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12851129 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12002009 |
| 95 | * JUN_21703547_ChIP-Seq_K562_Human | 1.11248005 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11017277 |
| 97 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10031582 |
| 98 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.09627274 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09098308 |
| 100 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09098308 |
| 101 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.09080032 |
| 102 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.08303636 |
| 103 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.08303636 |
| 104 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.07669879 |
| 105 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.07616810 |
| 106 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07437742 |
| 107 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.07222087 |
| 108 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.06885425 |
| 109 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06876101 |
| 110 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.06627310 |
| 111 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06382734 |
| 112 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05983055 |
| 113 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05972966 |
| 114 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.05735718 |
| 115 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.05017382 |
| 116 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04995934 |
| 117 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04848738 |
| 118 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04190167 |
| 119 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03388001 |
| 120 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.03260067 |
| 121 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.03215340 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02677093 |
| 123 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01852900 |
| 124 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01763629 |
| 125 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01683982 |
| 126 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01361368 |
| 127 | KDM2B_26808549_Chip-Seq_REH_Human | 1.00057407 |
| 128 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99847315 |
| 129 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99036529 |
| 130 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.98984643 |
| 131 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98727798 |
| 132 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.97613345 |
| 133 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96562187 |
| 134 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96322059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 6.08730061 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 6.00274456 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.10600711 |
| 4 | MP0009745_abnormal_behavioral_response | 3.58486187 |
| 5 | MP0004270_analgesia | 3.54655481 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.50240275 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.41999851 |
| 8 | MP0002064_seizures | 3.20214287 |
| 9 | MP0009046_muscle_twitch | 3.06247074 |
| 10 | MP0002736_abnormal_nociception_after | 3.04149180 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.99070793 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.92797265 |
| 13 | MP0002272_abnormal_nervous_system | 2.64307473 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.60929916 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.48073644 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.45545318 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.45326279 |
| 18 | MP0001486_abnormal_startle_reflex | 2.32817875 |
| 19 | MP0002067_abnormal_sensory_capabilities | 2.20237515 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.07425970 |
| 21 | MP0008057_abnormal_DNA_replication | 1.98011687 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 1.94597887 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.92724824 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.90793476 |
| 25 | MP0003879_abnormal_hair_cell | 1.88619583 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.86683770 |
| 27 | MP0001970_abnormal_pain_threshold | 1.86682488 |
| 28 | MP0001188_hyperpigmentation | 1.84769171 |
| 29 | MP0000778_abnormal_nervous_system | 1.84046612 |
| 30 | MP0003787_abnormal_imprinting | 1.82806854 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.81354728 |
| 32 | MP0002184_abnormal_innervation | 1.80998506 |
| 33 | MP0002822_catalepsy | 1.77288848 |
| 34 | MP0006276_abnormal_autonomic_nervous | 1.69545954 |
| 35 | MP0004924_abnormal_behavior | 1.69208286 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.69208286 |
| 37 | MP0001984_abnormal_olfaction | 1.67307952 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.65038893 |
| 39 | MP0003329_amyloid_beta_deposits | 1.58730644 |
| 40 | MP0008569_lethality_at_weaning | 1.55992989 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.55697385 |
| 42 | MP0002638_abnormal_pupillary_reflex | 1.50404675 |
| 43 | MP0001529_abnormal_vocalization | 1.44642215 |
| 44 | * MP0004811_abnormal_neuron_physiology | 1.44595267 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.40026164 |
| 46 | MP0000955_abnormal_spinal_cord | 1.35292898 |
| 47 | MP0002066_abnormal_motor_capabilities/c | 1.32517016 |
| 48 | MP0010234_abnormal_vibrissa_follicle | 1.31421891 |
| 49 | MP0006072_abnormal_retinal_apoptosis | 1.30585794 |
| 50 | MP0005174_abnormal_tail_pigmentation | 1.30310537 |
| 51 | * MP0002882_abnormal_neuron_morphology | 1.29229109 |
| 52 | MP0000427_abnormal_hair_cycle | 1.27221357 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.25561854 |
| 54 | MP0001905_abnormal_dopamine_level | 1.23720735 |
| 55 | MP0004142_abnormal_muscle_tone | 1.23338997 |
| 56 | MP0001502_abnormal_circadian_rhythm | 1.22737496 |
| 57 | MP0000751_myopathy | 1.21958374 |
| 58 | MP0004858_abnormal_nervous_system | 1.21855676 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.21387651 |
| 60 | MP0003633_abnormal_nervous_system | 1.19661877 |
| 61 | MP0005253_abnormal_eye_physiology | 1.16924385 |
| 62 | MP0004484_altered_response_of | 1.16773805 |
| 63 | MP0003045_fibrosis | 1.15919749 |
| 64 | MP0003122_maternal_imprinting | 1.12015610 |
| 65 | MP0004043_abnormal_pH_regulation | 1.08289836 |
| 66 | MP0004215_abnormal_myocardial_fiber | 1.04008949 |
| 67 | MP0003631_nervous_system_phenotype | 1.02959711 |
| 68 | * MP0002152_abnormal_brain_morphology | 1.00005993 |
| 69 | MP0002928_abnormal_bile_duct | 0.96903232 |
| 70 | MP0005171_absent_coat_pigmentation | 0.96534978 |
| 71 | MP0005645_abnormal_hypothalamus_physiol | 0.95930023 |
| 72 | MP0001963_abnormal_hearing_physiology | 0.95349718 |
| 73 | MP0010386_abnormal_urinary_bladder | 0.95328063 |
| 74 | MP0008872_abnormal_physiological_respon | 0.94584689 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 0.94317817 |
| 76 | MP0004085_abnormal_heartbeat | 0.92965609 |
| 77 | MP0005409_darkened_coat_color | 0.90981464 |
| 78 | MP0003698_abnormal_male_reproductive | 0.90540923 |
| 79 | MP0004742_abnormal_vestibular_system | 0.90101317 |
| 80 | MP0008877_abnormal_DNA_methylation | 0.89940770 |
| 81 | MP0004885_abnormal_endolymph | 0.89579696 |
| 82 | MP0008874_decreased_physiological_sensi | 0.89199373 |
| 83 | MP0003690_abnormal_glial_cell | 0.87645977 |
| 84 | MP0001929_abnormal_gametogenesis | 0.86361854 |
| 85 | MP0005389_reproductive_system_phenotype | 0.85730640 |
| 86 | MP0002229_neurodegeneration | 0.85436006 |
| 87 | MP0010678_abnormal_skin_adnexa | 0.84507452 |
| 88 | MP0002166_altered_tumor_susceptibility | 0.84185840 |
| 89 | MP0002095_abnormal_skin_pigmentation | 0.83854987 |
| 90 | MP0003195_calcinosis | 0.83498506 |
| 91 | MP0004510_myositis | 0.82946333 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.82867821 |
| 93 | MP0002160_abnormal_reproductive_system | 0.82351637 |
| 94 | MP0002069_abnormal_eating/drinking_beha | 0.82350090 |
| 95 | MP0002210_abnormal_sex_determination | 0.81337089 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.78032403 |
| 97 | MP0001485_abnormal_pinna_reflex | 0.77845552 |
| 98 | MP0005394_taste/olfaction_phenotype | 0.75847935 |
| 99 | MP0005499_abnormal_olfactory_system | 0.75847935 |
| 100 | MP0002752_abnormal_somatic_nervous | 0.74664529 |
| 101 | MP0000631_abnormal_neuroendocrine_gland | 0.74116407 |
| 102 | MP0000013_abnormal_adipose_tissue | 0.73784553 |
| 103 | MP0005535_abnormal_body_temperature | 0.73432413 |
| 104 | MP0005220_abnormal_exocrine_pancreas | 0.70905549 |
| 105 | MP0002102_abnormal_ear_morphology | 0.69627421 |
| 106 | MP0000920_abnormal_myelination | 0.68645649 |
| 107 | MP0004233_abnormal_muscle_weight | 0.67645250 |
| 108 | MP0008058_abnormal_DNA_repair | 0.67313125 |
| 109 | MP0001664_abnormal_digestion | 0.67279342 |
| 110 | MP0003632_abnormal_nervous_system | 0.65073470 |
| 111 | MP0000026_abnormal_inner_ear | 0.64706539 |
| 112 | MP0000653_abnormal_sex_gland | 0.64673262 |
| 113 | MP0006292_abnormal_olfactory_placode | 0.64303040 |
| 114 | MP0000604_amyloidosis | 0.62974082 |
| 115 | MP0001177_atelectasis | 0.58333751 |
| 116 | MP0003183_abnormal_peptide_metabolism | 0.58017094 |
| 117 | MP0003646_muscle_fatigue | 0.56815515 |
| 118 | MP0001943_abnormal_respiration | 0.56580164 |
| 119 | MP0005620_abnormal_muscle_contractility | 0.55195780 |
| 120 | MP0004036_abnormal_muscle_relaxation | 0.53388742 |
| 121 | MP0003121_genomic_imprinting | 0.52437549 |
| 122 | MP0002751_abnormal_autonomic_nervous | 0.51936838 |
| 123 | MP0000015_abnormal_ear_pigmentation | 0.51738817 |
| 124 | MP0005623_abnormal_meninges_morphology | 0.51504568 |
| 125 | MP0010770_preweaning_lethality | 0.50807337 |
| 126 | MP0002082_postnatal_lethality | 0.50807337 |
| 127 | MP0010769_abnormal_survival | 0.49916414 |
| 128 | MP0003137_abnormal_impulse_conducting | 0.49754222 |
| 129 | MP0005187_abnormal_penis_morphology | 0.48629259 |
| 130 | * MP0003861_abnormal_nervous_system | 0.48323605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.26435666 |
| 2 | Epileptic encephalopathy (HP:0200134) | 6.38847963 |
| 3 | Atonic seizures (HP:0010819) | 6.37032153 |
| 4 | Focal seizures (HP:0007359) | 6.00115694 |
| 5 | Febrile seizures (HP:0002373) | 5.67755711 |
| 6 | Hyperventilation (HP:0002883) | 5.50892784 |
| 7 | Absence seizures (HP:0002121) | 5.05080258 |
| 8 | Myokymia (HP:0002411) | 4.97764343 |
| 9 | Visual hallucinations (HP:0002367) | 4.75101601 |
| 10 | Dialeptic seizures (HP:0011146) | 4.68465432 |
| 11 | Broad-based gait (HP:0002136) | 4.25130126 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 4.20874801 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.98244693 |
| 14 | Amblyopia (HP:0000646) | 3.77455649 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 3.67636922 |
| 16 | Volvulus (HP:0002580) | 3.44572423 |
| 17 | Poor eye contact (HP:0000817) | 3.44472290 |
| 18 | Drooling (HP:0002307) | 3.22302191 |
| 19 | Excessive salivation (HP:0003781) | 3.22302191 |
| 20 | Truncal ataxia (HP:0002078) | 3.06258499 |
| 21 | Protruding tongue (HP:0010808) | 3.04110718 |
| 22 | Epileptiform EEG discharges (HP:0011182) | 2.98135246 |
| 23 | Dysdiadochokinesis (HP:0002075) | 2.96774129 |
| 24 | Abnormal social behavior (HP:0012433) | 2.93758421 |
| 25 | Impaired social interactions (HP:0000735) | 2.93758421 |
| 26 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.93185859 |
| 27 | Thyroiditis (HP:0100646) | 2.91274802 |
| 28 | Absent speech (HP:0001344) | 2.91031525 |
| 29 | Impaired smooth pursuit (HP:0007772) | 2.87036422 |
| 30 | Dysmetria (HP:0001310) | 2.81610432 |
| 31 | Scanning speech (HP:0002168) | 2.80303053 |
| 32 | Inability to walk (HP:0002540) | 2.77604054 |
| 33 | Dysmetric saccades (HP:0000641) | 2.67056341 |
| 34 | Papilledema (HP:0001085) | 2.64194004 |
| 35 | Oligodactyly (hands) (HP:0001180) | 2.61967761 |
| 36 | Abnormality of the axillary hair (HP:0100134) | 2.51952844 |
| 37 | Abnormality of secondary sexual hair (HP:0009888) | 2.51952844 |
| 38 | EEG with generalized epileptiform discharges (HP:0011198) | 2.51762235 |
| 39 | Action tremor (HP:0002345) | 2.50518790 |
| 40 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.49442952 |
| 41 | Hemiparesis (HP:0001269) | 2.48722931 |
| 42 | Genetic anticipation (HP:0003743) | 2.45798393 |
| 43 | Amyotrophic lateral sclerosis (HP:0007354) | 2.44634158 |
| 44 | Hemiplegia (HP:0002301) | 2.44272719 |
| 45 | Abnormal eating behavior (HP:0100738) | 2.42772525 |
| 46 | Depression (HP:0000716) | 2.42008752 |
| 47 | Anxiety (HP:0000739) | 2.40097861 |
| 48 | Gait imbalance (HP:0002141) | 2.39940337 |
| 49 | Termporal pattern (HP:0011008) | 2.39289090 |
| 50 | Insidious onset (HP:0003587) | 2.39289090 |
| 51 | Neoplasm of the adrenal cortex (HP:0100641) | 2.36134822 |
| 52 | Abnormality of binocular vision (HP:0011514) | 2.34930656 |
| 53 | Diplopia (HP:0000651) | 2.34930656 |
| 54 | Stereotypic behavior (HP:0000733) | 2.34803861 |
| 55 | Stomach cancer (HP:0012126) | 2.34631549 |
| 56 | Supranuclear gaze palsy (HP:0000605) | 2.34559164 |
| 57 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.32657992 |
| 58 | Status epilepticus (HP:0002133) | 2.32621568 |
| 59 | Blue irides (HP:0000635) | 2.30627811 |
| 60 | Abnormal hair whorl (HP:0010721) | 2.30493978 |
| 61 | Increased circulating renin level (HP:0000848) | 2.27633753 |
| 62 | Bundle branch block (HP:0011710) | 2.26201880 |
| 63 | Abnormality of the lower motor neuron (HP:0002366) | 2.25569388 |
| 64 | Hyperkalemia (HP:0002153) | 2.23790214 |
| 65 | Cerebral inclusion bodies (HP:0100314) | 2.23502239 |
| 66 | Hypsarrhythmia (HP:0002521) | 2.21392376 |
| 67 | Abnormality of the renal cortex (HP:0011035) | 2.21000337 |
| 68 | Fair hair (HP:0002286) | 2.20436211 |
| 69 | Fetal akinesia sequence (HP:0001989) | 2.19505509 |
| 70 | Abnormality of salivation (HP:0100755) | 2.18036327 |
| 71 | Short chin (HP:0000331) | 2.16728088 |
| 72 | Progressive inability to walk (HP:0002505) | 2.15763292 |
| 73 | Congenital primary aphakia (HP:0007707) | 2.15537751 |
| 74 | Medial flaring of the eyebrow (HP:0010747) | 2.15239122 |
| 75 | Impaired vibratory sensation (HP:0002495) | 2.14917677 |
| 76 | Generalized hypopigmentation of hair (HP:0011358) | 2.14377298 |
| 77 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.14136968 |
| 78 | Pancreatic cysts (HP:0001737) | 2.13422291 |
| 79 | Intention tremor (HP:0002080) | 2.09920578 |
| 80 | Syncope (HP:0001279) | 2.08823162 |
| 81 | Generalized myoclonic seizures (HP:0002123) | 2.08502996 |
| 82 | Dry hair (HP:0011359) | 2.07883119 |
| 83 | Horizontal nystagmus (HP:0000666) | 2.04742503 |
| 84 | Hyperthyroidism (HP:0000836) | 2.04595421 |
| 85 | Urinary urgency (HP:0000012) | 2.04077714 |
| 86 | Thickened helices (HP:0000391) | 2.01587951 |
| 87 | Abnormality of the corticospinal tract (HP:0002492) | 1.99819190 |
| 88 | Bradykinesia (HP:0002067) | 1.99365776 |
| 89 | Postural instability (HP:0002172) | 1.98997586 |
| 90 | Nephrogenic diabetes insipidus (HP:0009806) | 1.98468340 |
| 91 | Polydipsia (HP:0001959) | 1.97321009 |
| 92 | Abnormal drinking behavior (HP:0030082) | 1.97321009 |
| 93 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.96290411 |
| 94 | Absent/shortened dynein arms (HP:0200106) | 1.96290411 |
| 95 | Delusions (HP:0000746) | 1.95322872 |
| 96 | Acute necrotizing encephalopathy (HP:0006965) | 1.94703895 |
| 97 | Congenital, generalized hypertrichosis (HP:0004540) | 1.93778425 |
| 98 | Incomplete penetrance (HP:0003829) | 1.93452225 |
| 99 | Intestinal atresia (HP:0011100) | 1.92396342 |
| 100 | Widely spaced teeth (HP:0000687) | 1.91670194 |
| 101 | Abnormality of the renal medulla (HP:0100957) | 1.90370743 |
| 102 | Progressive macrocephaly (HP:0004481) | 1.89601625 |
| 103 | Polyphagia (HP:0002591) | 1.88636291 |
| 104 | Lower limb amyotrophy (HP:0007210) | 1.87673924 |
| 105 | Gait ataxia (HP:0002066) | 1.87671425 |
| 106 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.87592520 |
| 107 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.87592520 |
| 108 | Papillary thyroid carcinoma (HP:0002895) | 1.87517315 |
| 109 | Pancreatic fibrosis (HP:0100732) | 1.87512430 |
| 110 | Congenital stationary night blindness (HP:0007642) | 1.86858011 |
| 111 | Specific learning disability (HP:0001328) | 1.85186936 |
| 112 | True hermaphroditism (HP:0010459) | 1.83054655 |
| 113 | Decreased circulating renin level (HP:0003351) | 1.82922847 |
| 114 | Gastroesophageal reflux (HP:0002020) | 1.81825095 |
| 115 | Pheochromocytoma (HP:0002666) | 1.81643618 |
| 116 | Ventricular fibrillation (HP:0001663) | 1.80867617 |
| 117 | Sensory axonal neuropathy (HP:0003390) | 1.80800229 |
| 118 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.79984056 |
| 119 | Agammaglobulinemia (HP:0004432) | 1.79279140 |
| 120 | Chronic sinusitis (HP:0011109) | 1.79106534 |
| 121 | Exotropia (HP:0000577) | 1.78884616 |
| 122 | Hypothermia (HP:0002045) | 1.77145757 |
| 123 | Lower limb muscle weakness (HP:0007340) | 1.76853823 |
| 124 | Hypoventilation (HP:0002791) | 1.76336243 |
| 125 | Nephronophthisis (HP:0000090) | 1.76202954 |
| 126 | Tubulointerstitial nephritis (HP:0001970) | 1.75231757 |
| 127 | Spastic gait (HP:0002064) | 1.73615479 |
| 128 | Abnormality of the labia minora (HP:0012880) | 1.72441066 |
| 129 | Thyroid-stimulating hormone excess (HP:0002925) | 1.71402683 |
| 130 | Abnormal EKG (HP:0003115) | 1.70586343 |
| 131 | Abnormality of B cell number (HP:0010975) | 1.68805946 |
| 132 | Ankle clonus (HP:0011448) | 1.68434406 |
| 133 | Limb dystonia (HP:0002451) | 1.67405319 |
| 134 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.66854274 |
| 135 | Hydroureter (HP:0000072) | 1.66313947 |
| 136 | Deeply set eye (HP:0000490) | 1.65774762 |
| 137 | Autism (HP:0000717) | 1.65753378 |
| 138 | Psychosis (HP:0000709) | 1.64148735 |
| 139 | Supernumerary spleens (HP:0009799) | 1.64049858 |
| 140 | Heart block (HP:0012722) | 1.63833196 |
| 141 | Retinal dysplasia (HP:0007973) | 1.63276742 |
| 142 | Poor coordination (HP:0002370) | 1.63248790 |
| 143 | Shoulder girdle muscle weakness (HP:0003547) | 1.62980403 |
| 144 | Hematochezia (HP:0002573) | 1.61119749 |
| 145 | Prolonged QT interval (HP:0001657) | 1.60977507 |
| 146 | Optic nerve hypoplasia (HP:0000609) | 1.60784186 |
| 147 | Central scotoma (HP:0000603) | 1.58946605 |
| 148 | Slow-growing hair (HP:0002217) | 1.57520701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.41683201 |
| 2 | EPHA4 | 5.19882483 |
| 3 | CASK | 4.89897644 |
| 4 | NTRK3 | 4.50198144 |
| 5 | MAP3K4 | 3.18634456 |
| 6 | RIPK4 | 3.14456769 |
| 7 | MAP2K7 | 3.00063989 |
| 8 | DAPK2 | 2.86862783 |
| 9 | MAP3K9 | 2.71376589 |
| 10 | MAP3K12 | 2.69270670 |
| 11 | BMPR1B | 2.46872311 |
| 12 | DAPK1 | 2.35637445 |
| 13 | MINK1 | 2.12456111 |
| 14 | PNCK | 2.00141892 |
| 15 | CDK19 | 1.98876891 |
| 16 | CCNB1 | 1.96833928 |
| 17 | MAP2K4 | 1.88478043 |
| 18 | AKT3 | 1.72177335 |
| 19 | BMPR2 | 1.70168233 |
| 20 | KSR1 | 1.68284082 |
| 21 | MARK1 | 1.67316776 |
| 22 | STK38L | 1.66357935 |
| 23 | FGFR2 | 1.63123609 |
| 24 | EIF2AK3 | 1.56012677 |
| 25 | GRK5 | 1.55004494 |
| 26 | PINK1 | 1.51808946 |
| 27 | * PLK2 | 1.43581490 |
| 28 | PRPF4B | 1.43570259 |
| 29 | PAK6 | 1.40915102 |
| 30 | ACVR1B | 1.37225866 |
| 31 | NTRK2 | 1.35789236 |
| 32 | ARAF | 1.32766543 |
| 33 | KSR2 | 1.32273893 |
| 34 | ADRBK2 | 1.27916476 |
| 35 | CDK5 | 1.26149163 |
| 36 | PTK2B | 1.25716832 |
| 37 | FGFR3 | 1.24450095 |
| 38 | SIK2 | 1.23410242 |
| 39 | TNIK | 1.22319131 |
| 40 | CAMK2A | 1.21370263 |
| 41 | PRKCG | 1.20309792 |
| 42 | CAMKK2 | 1.19184547 |
| 43 | SIK3 | 1.15973351 |
| 44 | MAPK13 | 1.15818451 |
| 45 | STK24 | 1.15713042 |
| 46 | NME1 | 1.12449460 |
| 47 | NTRK1 | 1.11160522 |
| 48 | CAMK2B | 1.10214024 |
| 49 | MKNK2 | 1.07942525 |
| 50 | STK39 | 1.07653322 |
| 51 | OXSR1 | 1.07035356 |
| 52 | FES | 1.06872495 |
| 53 | CAMKK1 | 1.06330902 |
| 54 | TAOK3 | 0.98360786 |
| 55 | MAP3K13 | 0.96886791 |
| 56 | GRK1 | 0.94472308 |
| 57 | SGK2 | 0.93094580 |
| 58 | FGR | 0.88898984 |
| 59 | RAF1 | 0.87211307 |
| 60 | CAMK1G | 0.86819848 |
| 61 | WNK1 | 0.86485236 |
| 62 | ZAK | 0.86180694 |
| 63 | SGK223 | 0.83063656 |
| 64 | SGK494 | 0.83063656 |
| 65 | KIT | 0.83048220 |
| 66 | SYK | 0.82396374 |
| 67 | MAP4K2 | 0.81122518 |
| 68 | MAP3K2 | 0.77888489 |
| 69 | BRAF | 0.77244443 |
| 70 | CAMK1 | 0.73531455 |
| 71 | MET | 0.73445969 |
| 72 | NLK | 0.71199019 |
| 73 | CDK18 | 0.70417416 |
| 74 | WNK4 | 0.68718947 |
| 75 | GRK7 | 0.68200734 |
| 76 | NUAK1 | 0.67707446 |
| 77 | STK38 | 0.67407704 |
| 78 | ERBB3 | 0.66867385 |
| 79 | MAP2K6 | 0.65351668 |
| 80 | DYRK1A | 0.64156136 |
| 81 | CDK14 | 0.63408015 |
| 82 | CDK15 | 0.62876378 |
| 83 | * SGK1 | 0.62357596 |
| 84 | UHMK1 | 0.61537570 |
| 85 | CAMK2D | 0.61481275 |
| 86 | STK11 | 0.61429782 |
| 87 | BRD4 | 0.61087259 |
| 88 | OBSCN | 0.59726871 |
| 89 | DAPK3 | 0.59491955 |
| 90 | PDK4 | 0.56987613 |
| 91 | PDK3 | 0.56987613 |
| 92 | TGFBR1 | 0.56958110 |
| 93 | CSF1R | 0.56315824 |
| 94 | MARK2 | 0.55519166 |
| 95 | FER | 0.54243826 |
| 96 | CDK11A | 0.52332798 |
| 97 | GRK6 | 0.51875469 |
| 98 | PRKD3 | 0.51865568 |
| 99 | PDK1 | 0.51664526 |
| 100 | SGK3 | 0.51186360 |
| 101 | * PRKCE | 0.51115777 |
| 102 | TEC | 0.50600765 |
| 103 | BCR | 0.48742450 |
| 104 | MAPK12 | 0.48383783 |
| 105 | CSNK1G2 | 0.48087354 |
| 106 | PDPK1 | 0.47220982 |
| 107 | PRKG1 | 0.45431400 |
| 108 | STK3 | 0.45087789 |
| 109 | TNK2 | 0.44379878 |
| 110 | RET | 0.44175630 |
| 111 | MAPK7 | 0.43371863 |
| 112 | CDK3 | 0.43064944 |
| 113 | ADRBK1 | 0.42927981 |
| 114 | CSNK1G1 | 0.42912444 |
| 115 | ROCK2 | 0.42794552 |
| 116 | PKN1 | 0.42319563 |
| 117 | RPS6KB1 | 0.42296356 |
| 118 | CAMK2G | 0.42109597 |
| 119 | YES1 | 0.41316683 |
| 120 | WNK3 | 0.41298269 |
| 121 | MAP3K6 | 0.41202032 |
| 122 | MAPKAPK5 | 0.40834913 |
| 123 | PRKCQ | 0.40541268 |
| 124 | TRPM7 | 0.40290688 |
| 125 | CSNK1D | 0.40093413 |
| 126 | TAF1 | 0.39771412 |
| 127 | TSSK6 | 0.39664011 |
| 128 | PAK3 | 0.38173688 |
| 129 | CSNK1A1L | 0.37547664 |
| 130 | MAP2K1 | 0.37282325 |
| 131 | JAK1 | 0.36977696 |
| 132 | TYRO3 | 0.36509811 |
| 133 | RPS6KA3 | 0.36348354 |
| 134 | CAMK4 | 0.36034703 |
| 135 | MUSK | 0.35467656 |
| 136 | PHKG2 | 0.35356008 |
| 137 | PHKG1 | 0.35356008 |
| 138 | PRKACA | 0.34538708 |
| 139 | MAP3K1 | 0.34260676 |
| 140 | PRKCH | 0.33491580 |
| 141 | DMPK | 0.33174521 |
| 142 | LATS2 | 0.30833426 |
| 143 | NEK6 | 0.30728054 |
| 144 | PRKCZ | 0.29775611 |
| 145 | PRKCB | 0.28663239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.40340608 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.36989987 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 3.09298039 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.98720612 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.77871229 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.70392819 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.63272315 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.57937433 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.50110635 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.49211062 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.44996056 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.28024843 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.16531597 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.13652975 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.96405148 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.91675723 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.88855946 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88341942 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.83304808 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.80033828 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.76299095 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.75245560 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.73882481 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67826682 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.67387437 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.61298924 |
| 27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.52042444 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51120755 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.38668012 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.34449272 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32764706 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28566494 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.27733126 |
| 34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27216142 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.26345627 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.23135500 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.21956467 |
| 38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.21427480 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19617223 |
| 40 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.17860076 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.17548911 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.15024375 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.13536058 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.13533988 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.13220620 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 1.12782594 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12177870 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.12072223 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.10659412 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 1.08995356 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03536177 |
| 52 | Melanogenesis_Homo sapiens_hsa04916 | 1.03208778 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03157079 |
| 54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.00417967 |
| 55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.99914585 |
| 56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97971126 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.95028609 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.90804045 |
| 59 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90047906 |
| 60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88644966 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88338013 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85622212 |
| 63 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85179094 |
| 64 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.81330134 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.80274285 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77657847 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77564316 |
| 68 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73902143 |
| 69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72083508 |
| 70 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71115289 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70848186 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68144288 |
| 73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.67947245 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.67112208 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.65558527 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64806223 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64485449 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62720370 |
| 79 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62605358 |
| 80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62461528 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62037948 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61483491 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.61090820 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59830081 |
| 85 | Protein export_Homo sapiens_hsa03060 | 0.58779913 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58301358 |
| 87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56587660 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56370179 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55906410 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54422909 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54039991 |
| 92 | Basal transcription factors_Homo sapiens_hsa03022 | 0.52093519 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48558149 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47870169 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46900900 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46803263 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46200469 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45255643 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45009683 |
| 100 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44681019 |
| 101 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43798644 |
| 102 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41179027 |
| 103 | Tuberculosis_Homo sapiens_hsa05152 | 0.41043517 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.40699262 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40516601 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37627313 |
| 107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37330390 |
| 108 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.35916129 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35565264 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34451150 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34093403 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33924739 |
| 113 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33265438 |
| 114 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32720798 |
| 115 | Phagosome_Homo sapiens_hsa04145 | 0.32686121 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31422610 |
| 117 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31130712 |
| 118 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29512969 |
| 119 | Mineral absorption_Homo sapiens_hsa04978 | 0.28540146 |
| 120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28105336 |
| 121 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.26042074 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25486024 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.23427440 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.23301627 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23035126 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22520419 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22304172 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.21654864 |

